Accepted at 5:31 p.m. Oct, 31, 2023 by Alex
Author: pererh
Related Note: 1485197412342 2
Rationale for change

the uworld image and extra says how dantrolene/D2 agonist are if refractory. The card does not specify

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#AK_Step2_v12::#AMBOSS::4M03Kg #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::10_Retired_Lessons::04_Haloperidol,_trifluoperazine,_fluphenazine,_chlorpromazine,_thioridazine_[Retired_Video] #AK_Step2_v12::Original_decks::Dorian::psych::uw #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::New::08_Typical_Antipsychotics #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#AMBOSS::5TairP #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::10_Dantrolene #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::16_Neuroleptic_Malignant_Syndrome_(NMS) #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::03_Antipsychotics::*Typical_Antipsychotics #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::15_Extrapyramidal_Effects #AK_Other::AnKing_Image::!Subjects::Psychiatry::Neuroleptic_Malignant_Syndrome #AK_Other::AnKing_Image::Mujeeb::Malignant_hyperthermia_vs_neuroleptic_malignant_syndrome #AK_Other::AnKing_Image::!Subjects::Psychiatry::Malignant_hyperthermia_vs_neuroleptic_malignant_syndrome #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::16_Psychiatric_Emergencies #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::10_Dopamine_Agonists #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Step2_v12::Original_decks::Zanki_Step_2::Psych::UW_Psych #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::dorian #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::06_Pharm::*Spasmolytics_Antispasmodics::Dantrolene #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::zanki #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::08_Amantadine #AK_Step2_v12::#UWorld::Step::2501 #PANCE::EOR::Family_med #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::02_Antipsychotics #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::08_Muscle_Relaxants::01_Skeletal_Muscle_Relaxants #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::02_Typical_Antipsychotics #AK_Step1_v12::^Systems::Neuro::Pharmacology #PANCE::EOR::PSYCH #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#AMBOSS::wZahdQ #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::06_Bromocriptine_(Ergot_Dopamine_Agonists) #AK_Step1_v12::#UWorld::COMLEX::25613 #PANCE::BEHAVIORAL::bipolar #PANCE::BEHAVIORAL::schizophrenia #AK_Step1_v12::#UWorld::Step::512 #AK_Step2_v12::#NBME::Form15::Section_2 #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::02_Neuroleptic_Malignant_Syndrome #AK_Step2_v12::#UWorld::COMLEX::28315 #AK_Step2_v12::#Bootcamp::Psychiatry::01_Diagnosis_and_Management::02_Psychotic_Disorders::07_Neuroleptic_Malignant_Syndrome_and_Serotonin_Syndrome #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::15_Typical_Antipsychotics #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step2_v12::#SketchySurgery::01_Preoperative_&_Postoperative_Surgical_Considerations::02_Postoperative::01_Postoperative_Surgical_Fevers #AK_Step2_v12::#AMBOSS::Mn0MFg #AK_Step1_v12::#FirstAid::13_Psych::02_Pathology::40_Psychiatric_emergencies::*Neuroleptic_Malignant_Syndrome::Treatment #AK_Step1_v12::#UWorld::COMLEX::23625 #AK_Step1_v12::#UWorld::Step::11676 #AK_Other::AnKing_Image::AhmedA::Neuroleptic_Malignant_Syndrome #AK_Step2_v12::#AMBOSS::qn0C8g